Determining breast cancer axillary surgery within the surveillance epidemiology and end results-Medicare database

Ryan K. Schmocker, Holly Caretta-Weyer, Jennifer M. Weiss, Katie Ronk, Jeffrey Havlena, Noelle K. Loconte, Marquita Decker, Maureen A. Smith, Caprice C. Greenberg, Heather B. Neuman

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Background Use of sentinel lymph node biopsy (SLNB) is under-reported by cancer registries' "Scope of Regional Lymph Node Surgery" variable. In 2011, the Surveillance Epidemiology and End Results (SEER) Program recommended against its use to determine extent of axillary surgery, leaving a gap in the utilization of claims data for breast cancer research. The objective was to develop an algorithm using SEER registry and claims data to classify extent of axillary surgery for breast cancer. Methods We analyzed data for 24,534 breast cancer patients. CPT codes and number of examined lymph nodes classified the extent of axillary surgery. The final algorithm was validated by comparing the algorithm derived extent of axillary surgery to direct chart review for 100 breast cancer patients treated at our breast center. Results Using the algorithm, 13% had no axillary surgery, 56% SLNB and 31% axillary lymph node dissection (ALND). SLNB was performed in 77% of node negative patients and ALND in 72% of node positive. In our validation study, concordance between algorithm and direct chart review was 97%. Conclusions Given recognized inaccuracies in cancer registries' "Scope of Regional Lymph Node Surgery" variable, these findings have high utility for health services researchers studying breast cancer treatment.

Original languageEnglish (US)
Pages (from-to)756-759
Number of pages4
JournalJournal of Surgical Oncology
Volume109
Issue number8
DOIs
StatePublished - Jun 2014
Externally publishedYes

Keywords

  • axillary surgery
  • breast cancer
  • SEER-Medicare

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Determining breast cancer axillary surgery within the surveillance epidemiology and end results-Medicare database'. Together they form a unique fingerprint.

Cite this